Related references
Note: Only part of the references are listed.Early Human B Cell Response to Ebola Virus in Four US Survivors of Infection
Lauren E. Williamson et al.
JOURNAL OF VIROLOGY (2019)
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Carl W. Davis et al.
CELL (2019)
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates
Zachary A. Bornholdt et al.
CELL HOST & MICROBE (2019)
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
Anna Z. Wec et al.
CELL HOST & MICROBE (2019)
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
Pavlo Gilchuk et al.
IMMUNITY (2018)
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
Julie Dyall et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region
Andrew I. Flyak et al.
NATURE MICROBIOLOGY (2018)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus
Bronwyn M. Gunn et al.
CELL HOST & MICROBE (2018)
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Philipp A. Ilinykh et al.
PLOS PATHOGENS (2018)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice
Wenqian He et al.
NATURE COMMUNICATIONS (2017)
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections
Chasity D. Andrews et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1
Yoshiaki Nishimura et al.
CELL HOST & MICROBE (2017)
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Anna Z. Wec et al.
CELL (2017)
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2016)
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses
Frederick W. Holtsberg et al.
JOURNAL OF VIROLOGY (2016)
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency
Stylianos Bournazos et al.
CELL (2016)
Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection
David J. DiLillo et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Richard T. Davey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
Paul E. Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus
Wenqian He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Trojan horse bispecific-antibody strategy for broad protection against ebolaviruses
Anna Z. Wec et al.
SCIENCE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu et al.
SCIENCE (2016)
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
Zachary A. Bornholdt et al.
SCIENCE (2016)
Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus
Yu Cong et al.
PLOS ONE (2016)
Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
David J. DiLillo et al.
CELL (2015)
Fcγ receptor pathways during active and passive immunization
Stylianos Bournazos et al.
IMMUNOLOGICAL REVIEWS (2015)
The role of Fc-FcγR interactions in IgG-mediated microbial neutralization
Stylianos Bournazos et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity
Lisa M. Johansen et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Stylianos Bournazos et al.
CELL (2014)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity
Stylianos Bournazos et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo
David J. DiLillo et al.
NATURE MEDICINE (2014)
Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge
Shelley P. Honnold et al.
PLOS ONE (2014)
Molecular Characterization of the Monoclonal Antibodies Composing ZMAb: A Protective Cocktail Against Ebola Virus
Jonathan Audet et al.
SCIENTIFIC REPORTS (2014)
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
James Pettitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
Xiangguo Qiu et al.
SCIENTIFIC REPORTS (2013)
Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
Andrea Marzi et al.
PLOS ONE (2012)
A mouse model for HIV-1 entry
John Pietzsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Mouse model recapitulating human Fcγ receptor structural and functional diversity
Patrick Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A shared structural solution for neutralizing ebolaviruses
Joao M. Dias et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies
Holly M. Horton et al.
BLOOD (2010)
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms
Devon J. Shedlock et al.
VIROLOGY (2010)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Divergent immunoglobulin G subclass activity through selective Fc receptor binding
F Nimmerjahn et al.
SCIENCE (2005)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Share Paper
